Ovarian function and disorders
Ovarian function and disorders is a research topic within Reproductive Medicine. Science Explorer counts 48k research works in it since 1950. 25.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis and management of polycystic ovary syndrome (PCOS), covering topics such as ovarian reserve, insulin resistance, metabolic syndrome, androgen excess, fertility, anti-Mullerian hormone, cardiovascular disease, obesity, and infertility. The papers discuss various aspects of PCOS including its impact on long-term health risks, diagnostic criteria, treatment options, and the association with other conditions such as cardiovascular disease and metabolic syndrome.
- Polycystic Ovary Syndrome
- Ovarian Reserve
- Insulin Resistance
- Metabolic Syndrome
- Androgen Excess
- Fertility
- Anti-Mullerian Hormone
- Cardiovascular Disease
- Obesity
- Infertility
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 12k per year above
- Top-10% rate
- 25.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +34% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ovarian function and disorders research?
By volume, China and the United States publish the most (1.8k and 1.3k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.8k works
- 2 United States 1.3k works
- 3 India 837 works
- 4 Iran 414 works
- 5 Türkiye 394 works
- 6 Italy 287 works
- 7 United Kingdom 270 works
- 8 Brazil 259 works
- 9 Egypt 206 works
- 10 Spain 199 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ovarian function and disorders research?
By volume in 2022–2025, Monash University publishes the most Ovarian function and disorders research, followed by Tehran University of Medical Sciences and Sağlık Bilimleri Üniversitesi.
By volume, 2022–2025
- 1 Monash UniversityAustralia 34 works
- 2 Tehran University of Medical SciencesIran 31 works
- 3 Sağlık Bilimleri ÜniversitesiTürkiye 30 works
- 4 Harvard UniversityUnited States 30 works
- 5 Peking UniversityChina 30 works
- 6 First Affiliated Hospital of Zhengzhou UniversityChina 27 works
- 7 All India Institute of Medical SciencesIndia 26 works
- 8 Shanghai Jiao Tong UniversityChina 26 works
- 9 Cairo UniversityEgypt 25 works
- 10 Huazhong University of Science and TechnologyChina 24 works
Who are the leading researchers in Ovarian function and disorders?
The most-cited researchers publishing on Ovarian function and disorders include Patrick M. Bossuyt, Mohammad Alì Mansournia and Naveed Sattar.
- 1 Patrick M. Bossuyt Netherlands 14k citations
- 2 Mohammad Alì Mansournia Iran 4.2k citations
- 3 Naveed Sattar United Kingdom 3.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ovarian function and disorders research done?
The largest centres of Ovarian function and disorders research in 2022–2025 are Beijing (China), Tehran (Iran), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Yazd and Wardha.
Largest cities, 2022–2025
Where it is the local speciality
- YazdIR · 20.1 works12×
- WardhaIN · 22.3 works9.9×
Location quotient: how much more of its research is in Ovarian function and disorders than the world average.
Where is the best place to study Ovarian function and disorders?
Among universities, judged by research, Tehran University of Medical Sciences, Nanjing University of Chinese Medicine and Koç University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Tehran University of Medical SciencesIran | 62.0 | 27.4% | 7.8× | 31 | +49.4% |
| 2 | Nanjing University of Chinese MedicineChina | 60.9 | 31.9% | 7.4× | 16 | +297.3% |
| 3 | Koç UniversityTürkiye | 60.6 | 25.2% | 8.8× | 12 | +456.4% |
| 4 | Monash UniversityAustralia | 58.5 | 29.1% | 4.7× | 34 | +31.6% |
| 5 | Medical University of WarsawPoland | 56.7 | 44.2% | 5.1× | 10 | +385.3% |
| 6 | China Medical UniversityChina | 56.0 | 29.9% | 8.5× | 24 | -2.9% |
| 7 | Tabriz University of Medical SciencesIran | 56.0 | 25.8% | 7.8× | 16 | +125.7% |
| 8 | Shahid Beheshti University of Medical SciencesIran | 55.2 | 22.2% | 7.4× | 23 | +89.2% |
| 9 | Afe Babalola UniversityNigeria | 55.0 | 35.8% | 11.6× | 8 | — |
| 10 | Medical University of SilesiaPoland | 53.1 | 25.9% | 9.5× | 15 | +33.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Ovarian function and disorders research growing?
Output in 2018–2022 was 34% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Ovarian function and disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.